- Filed
- May 9, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2025 · May 9, 2025 | 704.6M sh |
| Cash And Equivalents | Q1 2025 · Mar 31, 2025 | $1.61M |
| Cash And Equivalents | Q1 2025 · Dec 31, 2024 | $2.1M |
| Current Liabilities | Q1 2025 · Mar 31, 2025 | $12.66K |
| Current Liabilities | Q1 2025 · Dec 31, 2024 | $7.98K |
| Current Assets | Q1 2025 · Mar 31, 2025 | $1.66M |
| Current Assets | Q1 2025 · Dec 31, 2024 | $2.11M |
| Total Assets | Q1 2025 · Mar 31, 2025 | $1.67M |
| Total Assets | Q1 2025 · Dec 31, 2024 | $2.13M |
| Shares Diluted | Q1 2025 · Mar 31, 2024 | 704.6M sh |
| Operating Cash Flow | Q1 2025 · Mar 31, 2024 | −$431.41K |
| Stockholders Equity | Q1 2025 · Mar 31, 2024 | −$177.58K |
| Stockholders Equity | Q1 2025 · Dec 31, 2023 | $217.14K |
| Eps Diluted | Q1 2025 · Mar 31, 2024 | $0.00 |
| Eps Basic | Q1 2025 · Mar 31, 2024 | $0.00 |
| Sga Expense restated | Q1 2025 · Mar 31, 2024 | $306.4K |
| Rd Expense | Q1 2025 · Mar 31, 2024 | $88.94K |
| Net Income | Q1 2025 · Mar 31, 2024 | −$471K |
| Operating Income | Q1 2025 · Mar 31, 2024 | −$471.34K |